PL2374472T3 - Kompozycje i sposoby leczenia zaburzeń okulistycznych - Google Patents

Kompozycje i sposoby leczenia zaburzeń okulistycznych

Info

Publication number
PL2374472T3
PL2374472T3 PL11152204T PL11152204T PL2374472T3 PL 2374472 T3 PL2374472 T3 PL 2374472T3 PL 11152204 T PL11152204 T PL 11152204T PL 11152204 T PL11152204 T PL 11152204T PL 2374472 T3 PL2374472 T3 PL 2374472T3
Authority
PL
Poland
Prior art keywords
compositions
methods
ophthalmic disorders
treating ophthalmic
treating
Prior art date
Application number
PL11152204T
Other languages
English (en)
Inventor
Pierre Belichard
Original Assignee
Dyax Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38573251&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2374472(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dyax Corp. filed Critical Dyax Corp.
Publication of PL2374472T3 publication Critical patent/PL2374472T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL11152204T 2006-03-16 2007-03-13 Kompozycje i sposoby leczenia zaburzeń okulistycznych PL2374472T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06360008 2006-03-16
EP06291516 2006-09-26
EP07005182.6A EP1854477B9 (en) 2006-03-16 2007-03-13 Peptides inhibiting plasma kallikrein for use in the treatment of ophthalmic disorders.
EP11152204.1A EP2374472B9 (en) 2006-03-16 2007-03-13 Compositions and methods for treating ophthalmic disorders

Publications (1)

Publication Number Publication Date
PL2374472T3 true PL2374472T3 (pl) 2018-11-30

Family

ID=38573251

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11152204T PL2374472T3 (pl) 2006-03-16 2007-03-13 Kompozycje i sposoby leczenia zaburzeń okulistycznych

Country Status (5)

Country Link
EP (2) EP2374472B9 (pl)
CY (2) CY1118767T1 (pl)
DK (1) DK2374472T3 (pl)
PL (1) PL2374472T3 (pl)
SI (1) SI1854477T1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3299377T1 (sl) 2011-10-07 2021-07-30 Bicyclerd Limited Modulacija strukturirane specifičnosti polipeptida
GB201306623D0 (en) * 2013-04-11 2013-05-29 Bicycle Therapeutics Ltd Modulation of structured polypeptide specificity

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079A (en) 1845-06-10 Corn-shei
US38A (en) 1836-10-04 Horizontal boot-clamp
US4131648A (en) 1975-01-28 1978-12-26 Alza Corporation Structured orthoester and orthocarbonate drug delivery devices
US4093709A (en) 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4180646A (en) 1975-01-28 1979-12-25 Alza Corporation Novel orthoester polymers and orthocarbonate polymers
US4079038A (en) 1976-03-05 1978-03-14 Alza Corporation Poly(carbonates)
JPS6056684B2 (ja) 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
US4271143A (en) 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
US4407792A (en) 1979-05-09 1983-10-04 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
US4304767A (en) 1980-05-15 1981-12-08 Sri International Polymers of di- (and higher functionality) ketene acetals and polyols
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
EP0501523B1 (en) 1983-11-14 1997-04-09 Columbia Laboratories, Inc. Bioadhesive compositions
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US5187153A (en) 1986-11-17 1993-02-16 Scios Nova Inc. Methods of treatment using Alzheimer's amyloid polypeptide derivatives
US4946931A (en) 1989-06-14 1990-08-07 Pharmaceutical Delivery Systems, Inc. Polymers containing carboxy-ortho ester and ortho ester linkages
US5041434A (en) 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
PT739355E (pt) 1994-01-11 2005-01-31 Dyax Corp Proteinas de 'dominio de kunitz' inibidoras de calicreina e seus analogos
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
ES2375561T3 (es) 1994-01-11 2012-03-02 Dyax Corporation Inhibidores de la plasmina humana derivados de dominios kunitz y �?cidos nucleicos que codifican los mismos.
US5786328A (en) 1995-06-05 1998-07-28 Genentech, Inc. Use of kunitz type plasma kallikrein inhibitors
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US5968543A (en) 1996-01-05 1999-10-19 Advanced Polymer Systems, Inc. Polymers with controlled physical state and bioerodibility
US6087473A (en) 1999-05-26 2000-07-11 Zymogenetics, Inc. Kunitz domain polypeptide and materials and methods for making it
US6174859B1 (en) * 1999-04-06 2001-01-16 J & D Sciences, Inc. Method of treatment
AU6526100A (en) 1999-08-06 2001-03-05 Board Of Regents, The University Of Texas System Drug releasing biodegradable fiber implant
US6613355B2 (en) 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US6524606B1 (en) 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
ATE477020T1 (de) 2002-06-07 2010-08-15 Dyax Corp Prevention und verringerung von ischemia
US6989369B2 (en) * 2003-02-07 2006-01-24 Dyax Corp. Kunitz domain peptides
WO2005021557A2 (en) 2003-08-29 2005-03-10 Dyax Corp. Poly-pegylated protease inhibitors
EP1736465A4 (en) 2004-03-31 2009-06-17 Ajinomoto Kk ANILINE DERIVATIVES
EP2500031A3 (en) 2005-02-24 2012-12-26 Joslin Diabetes Center, Inc. Compositions and Methods for Treating Vascular Permeability
WO2008016883A2 (en) 2006-07-31 2008-02-07 Activesite Pharmaceuticals, Inc. Inhibitors of plasma kallikrein

Also Published As

Publication number Publication date
CY1118767T1 (el) 2017-07-12
DK2374472T3 (en) 2018-08-13
EP1854477B9 (en) 2018-03-14
EP2374472B9 (en) 2019-06-12
EP2374472A2 (en) 2011-10-12
SI1854477T1 (sl) 2017-01-31
EP2374472B1 (en) 2018-05-02
EP1854477A3 (en) 2008-06-11
CY1121044T1 (el) 2019-12-11
EP2374472A3 (en) 2012-05-16
EP1854477B1 (en) 2016-08-03
EP1854477A2 (en) 2007-11-14

Similar Documents

Publication Publication Date Title
HUE039108T2 (hu) Készítmények és eljárások szembetegségek kezelésére
IL291175A (en) Compositions and methods for treating collagen-mediated diseases
EP2170309A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF DISEASES
HRP20182135T1 (hr) Pripravci za i postupci liječenja poremećaja povezanih s ige
ZA200700918B (en) Compositions and methods for treating eye disorders and conditions
EP2083862A4 (en) COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES AND DISORDERS
LT2444079T (lt) Kompozicijos ir būdai, skirti akių sutrikimų gydymui
IL202573A0 (en) Methods and compositions for treating allergic diseases
GB2466912B (en) Compositions and methods for treating lysosomal disorders
GB0818413D0 (en) CD47 Related compositions and methods for treating immunological diseases and disorders
EP1893216A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES
IL193936A0 (en) Compositions and methods for the treatment of immunoinflammatory disorders
IL198723A0 (en) Methods and compositions for therapeutic treatment
IL193697A0 (en) Methods for treating cognitive and other disorders
GB0718918D0 (en) Compositions and methods for treating skin conditions
IL196638A0 (en) Methods and compositions for treating disease
PL2056799T3 (pl) Kompozycje i sposoby do leczenia lub zapobiegania jaskrze lub jej rozwojowi
PL2374472T3 (pl) Kompozycje i sposoby leczenia zaburzeń okulistycznych
ZA200807049B (en) Compositions and methods for treating collagen-mediated diseases
HK1103984A (en) Compositions and methods for treating eye disorders and conditions